117 related articles for article (PubMed ID: 6319849)
1. Rat brain enkephalinase: characterization of the active site using mercaptopropanoyl amino acid inhibitors, and comparison with angiotensin-converting enzyme.
Gordon EM; Cushman DW; Tung R; Cheung HS; Wang FL; Delaney NG
Life Sci; 1983; 33 Suppl 1():113-6. PubMed ID: 6319849
[TBL] [Abstract][Full Text] [Related]
2. In vivo 'enkephalinase' inhibition by acetorphan in human plasma and CSF.
Spillantini MG; Geppetti P; Fanciullacci M; Michelacci S; Lecomte JM; Sicuteri F
Eur J Pharmacol; 1986 Jun; 125(1):147-50. PubMed ID: 3015640
[TBL] [Abstract][Full Text] [Related]
3. Degradation of neurotensin by rat brain synaptic membranes: involvement of a thermolysin-like metalloendopeptidase (enkephalinase), angiotensin-converting enzyme, and other unidentified peptidases.
Checler F; Vincent JP; Kitabgi P
J Neurochem; 1983 Aug; 41(2):375-84. PubMed ID: 6308159
[TBL] [Abstract][Full Text] [Related]
4. The role of bestatin-sensitive aminopeptidase, angiotensin converting enzyme and thiorphan-sensitive "enkephalinase" in the potency of enkephalins in the guinea-pig ileum.
Aoki K; Kajiwara M; Oka T
Jpn J Pharmacol; 1984 Sep; 36(1):59-65. PubMed ID: 6094902
[TBL] [Abstract][Full Text] [Related]
5. Enantiomers of [R,S]-thiorphan: dissociation of analgesia from enkephalinase A inhibition.
Scott WL; Mendelsohn LG; Cohen ML; Evans DA; Frederickson RC
Life Sci; 1985 Apr; 36(13):1307-13. PubMed ID: 2984500
[TBL] [Abstract][Full Text] [Related]
6. Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphan.
Roques BP; Lucas-Soroca E; Chaillet P; Costentin J; Fournié-Zaluski MC
Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3178-82. PubMed ID: 6304695
[TBL] [Abstract][Full Text] [Related]
7. Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition.
Patey G; De La Baume S; Schwartz JC; Gros C; Roques B; Fournie-Zaluski MC; Soroca-Lucas E
Science; 1981 Jun; 212(4499):1153-5. PubMed ID: 7015510
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of the hypoglycemic effect of insulin by thiorphan, an enkephalinase inhibitor.
Chipkin RE; Kreutner W; Billard W
Eur J Pharmacol; 1984 Jun; 102(1):151-4. PubMed ID: 6383841
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of two probes for the localisation of enkephalinase in rat brain: [3H]thiorphan and a 125I-labeled monoclonal antibody.
Pollard H; De la Baume S; Bouthenet ML; Schwartz JC; Ronco P; Verroust P
Eur J Pharmacol; 1987 Jan; 133(2):155-64. PubMed ID: 3545855
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological "enkephalinase" inhibition in man.
Marcello F; Grazia SM; Sergio M; Federigo S
Adv Exp Med Biol; 1986; 198 Pt B():153-60. PubMed ID: 3028074
[TBL] [Abstract][Full Text] [Related]
11. The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice.
Roques BP; Fournié-Zaluski MC; Soroca E; Lecomte JM; Malfroy B; Llorens C; Schwartz JC
Nature; 1980 Nov; 288(5788):286-8. PubMed ID: 7001254
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of angiotensin-converting enzyme by derivatives of 3-mercapto-2-methylpropanoyl glycine.
Schwab A; Weinryb I; Macerata R; Rogers W; Suh J; Khandwala A
Biochem Pharmacol; 1983 Jun; 32(12):1957-60. PubMed ID: 6309188
[No Abstract] [Full Text] [Related]
13. New enkephalinase inhibitors as probes to differentiate "enkephalinase" and angiotensin-converting-enzyme active sites.
Roques BP; Fournié-Zaluski MC; Florentin D; Waksman G; Sassi A; Chaillet P; Collado H; Costentin J
Life Sci; 1982 Oct 18-25; 31(16-17):1749-52. PubMed ID: 6296575
[No Abstract] [Full Text] [Related]
14. Enkephalinase 'A' inhibition by thiorphan: central and peripheral cardiovascular effects.
Baum T; Becker FT; Sybertz EJ; Sabin C; Desiderio DM
Eur J Pharmacol; 1983 Oct; 94(1-2):85-91. PubMed ID: 6360696
[TBL] [Abstract][Full Text] [Related]
15. Comparison of dipeptidyl carboxypeptidase and endopeptidase activities in the three enkephalin-hydrolysing metallopeptidases: "angiotensin-converting enzyme", thermolysin and "enkephalinase".
Malfroy B; Schwartz JC
Biochem Biophys Res Commun; 1985 Jul; 130(1):372-8. PubMed ID: 2992465
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of enkephalinase, angiotensin converting enzyme, and a third peptidyldipeptidase from rat brain.
Cushman DW; Gordon EM; Wang FL; Cheung HS; Tung R; Delaney NG
Life Sci; 1983; 33 Suppl 1():25-8. PubMed ID: 6319870
[TBL] [Abstract][Full Text] [Related]
17. Naloxone-reversible antidiarrheal effects of enkephalinase inhibitors.
Marçais-Collado H; Uchida G; Costentin J; Schwartz JC; Lecomte JM
Eur J Pharmacol; 1987 Dec; 144(2):125-32. PubMed ID: 3481337
[TBL] [Abstract][Full Text] [Related]
18. Naloxone-insensitive potentiation of neurotensin hypothermic effect by the enkephalinase inhibitor thiorphan.
Coquerel A; Dubuc I; Menard JF; Kitabgi P; Costentin J
Brain Res; 1986 Nov; 398(2):386-9. PubMed ID: 3542125
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the inhibitory potencies of thiorphan and retrothiorphan enantiomers on thermolysin and neutral endopeptidase 24.11 and their interactions with the thermolysin active site by computer modelling.
Benchetrit T; Fournié-Zaluski MC; Roques BP
Biochem Biophys Res Commun; 1987 Sep; 147(3):1034-40. PubMed ID: 3478046
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the metabolism of substance P and neurotensin by human angiotensin I converting enzyme and "enkephalinase".
Skidgel RA
Prog Clin Biol Res; 1985; 192():371-8. PubMed ID: 2417254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
